Literature DB >> 6170341

Allergic neuritis: phospholipid requirement for the disease-inducing conformation of the P2 protein.

A Ishaque, I Szymanska, J Ramwani, E H Eylar.   

Abstract

The P2 protein, a small, highly ordered basic protein of peripheral nerve myelin, is a potent inducer of allergic neuritis in rats when complexed with phospholipids such as phosphatidylserine. Isolated P2 protein administered without lipid is a poor neuritogen, and if first oxidized with performic acid, aminoethylated in 8 M urea or heat denatured, it loses nearly all activity. When the aminoethylated or oxidized forms are combined with phosphatidylserine, however, they recover essentially full neuritogenic activity. Complexing with lipid also greatly enhances the activity of the heart denatured form. Spleen cells sensitized to the aminoethylated and heated forms of P2 protein show a pronounced mitogenic response to either of these forms as well as to the P2 protein itself, but only when sensitization is initiated with the lipid complex. These data indicate that the lipid complex reverses the distortion acquired by chemical treatment or denaturation and converts the P2 molecule into a conformation approximating that of the native P2 protein in myelin. These studies imply that the neuritogenic domain, while highly sensitive to denaturing conditions, requires interaction with phospholipids in order to attain the most favourable conformation for inducing a cell-mediated response that leads to disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170341     DOI: 10.1016/0005-2795(81)90219-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Degradation of bovine P2 protein by bovine brain cathepsin D.

Authors:  J N Whitaker; J M Seyer
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

2.  Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.

Authors:  Claudia Gonzaga-Jauregui; Tamar Harel; Tomasz Gambin; Maria Kousi; Laurie B Griffin; Ludmila Francescatto; Burcak Ozes; Ender Karaca; Shalini N Jhangiani; Matthew N Bainbridge; Kim S Lawson; Davut Pehlivan; Yuji Okamoto; Marjorie Withers; Pedro Mancias; Anne Slavotinek; Pamela J Reitnauer; Meryem T Goksungur; Michael Shy; Thomas O Crawford; Michel Koenig; Jason Willer; Brittany N Flores; Igor Pediaditrakis; Onder Us; Wojciech Wiszniewski; Yesim Parman; Anthony Antonellis; Donna M Muzny; Nicholas Katsanis; Esra Battaloglu; Eric Boerwinkle; Richard A Gibbs; James R Lupski
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

3.  Experimental allergic neuritis-like disease in rabbits after injection with influenza vaccines mixed with gangliosides and adjuvants.

Authors:  D W Ziegler; J J Gardner; D T Warfield; H H Walls
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

4.  Lipid content of swine influenza and other vaccines.

Authors:  K C Leskawa; E L Hogan; S Dasgupta; J L Chien; R E Erwin; S W Brostoff
Journal:  Lipids       Date:  1986-05       Impact factor: 1.880

5.  Identification of a pathogenic PMP2 variant in a multi-generational family with CMT type 1: Clinical gene panels versus genome-wide approaches to molecular diagnosis.

Authors:  Jaya Punetha; Loren Mackay-Loder; Tamar Harel; Zeynep Coban-Akdemir; Shalini N Jhangiani; Richard A Gibbs; Ian Lee; Deborah Terespolsky; James R Lupski; Jennifer E Posey
Journal:  Mol Genet Metab       Date:  2018-08-24       Impact factor: 4.797

6.  Developmentally regulated mRNAs in 3T3-adipocytes: analysis of transcriptional control.

Authors:  K S Cook; C R Hunt; B M Spiegelman
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.